MX2007013298A - Metodo para preparar y usar composiciones de feromona esteroide basadas en agua. - Google Patents

Metodo para preparar y usar composiciones de feromona esteroide basadas en agua.

Info

Publication number
MX2007013298A
MX2007013298A MX2007013298A MX2007013298A MX2007013298A MX 2007013298 A MX2007013298 A MX 2007013298A MX 2007013298 A MX2007013298 A MX 2007013298A MX 2007013298 A MX2007013298 A MX 2007013298A MX 2007013298 A MX2007013298 A MX 2007013298A
Authority
MX
Mexico
Prior art keywords
pheromones
water
pigs
emulsions
steroid
Prior art date
Application number
MX2007013298A
Other languages
English (en)
Inventor
Norman Avelino
Jean Lafontaine
Original Assignee
Phero Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phero Tech Inc filed Critical Phero Tech Inc
Publication of MX2007013298A publication Critical patent/MX2007013298A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Esta invencion se relaciona con metodos para formular feromonas de esteroide como emulsiones estables novedosas. Estas emulsiones se pueden usar para administracion de feromonas de esteroide a organismos vivos tales como humanos y cerdos en lugar de formulaciones en aerosol con solvente organico o a presion actuales que presentan peligros tanto en embarque como aplicacion. Los usos relacionados con cerdos son el estimulo de maduracion sexual, diagnostico del principio y tiempo de ostro en cerdos hembra, e inducir a cerdos a aceptar cerdos falsos. Las emulsiones basadas en agua pueden incluir 5-androst-16-e-3-ona y 3-hidroxi-5??-androst-16-eno para administracion a cerdos. El uso de emulsiones basadas en agua elimina la necesidad de formulacion de las feromonas de esteroide en solventes organicos, entrega de estas feromonas como aerosoles a presion y siguiente las precauciones requeridas para reducir riesgos durante embarque y manejo. Las emulsiones basadas en agua permiten el tratamiento de organismos vivos en donde una formulacion de solvente organico liquido o de aerosol de las feromonas podria ser danina al organismo o a un substrato.
MX2007013298A 2005-05-06 2005-06-29 Metodo para preparar y usar composiciones de feromona esteroide basadas en agua. MX2007013298A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/123,032 US20060252738A1 (en) 2005-05-06 2005-05-06 Method for preparing and using water-based steroid pheromone compositions
PCT/CA2005/001027 WO2006119604A1 (en) 2005-05-06 2005-06-29 Method for preparing and using water-based steroid pheromone compositions

Publications (1)

Publication Number Publication Date
MX2007013298A true MX2007013298A (es) 2008-04-02

Family

ID=37394795

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007013298A MX2007013298A (es) 2005-05-06 2005-06-29 Metodo para preparar y usar composiciones de feromona esteroide basadas en agua.

Country Status (7)

Country Link
US (1) US20060252738A1 (es)
EP (1) EP1881836A4 (es)
CN (1) CN101217964A (es)
BR (1) BRPI0520265A2 (es)
CA (1) CA2606275C (es)
MX (1) MX2007013298A (es)
WO (1) WO2006119604A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8741965B2 (en) * 2011-09-20 2014-06-03 Sergeant's Pet Care Products, Inc. Method of administering a pheromone composition to an animal to modify the animals behavior over an extended period of time
US9480688B2 (en) 2011-09-20 2016-11-01 Sergeant's Pet Care Products, Inc. Pheromone compositions and their use to modify behavior in different vertebrate species
WO2013043879A1 (en) 2011-09-20 2013-03-28 Sergeants Pet Care Products, Inc. Interomone compositions and their use to modify behavior in different vertebrate species
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US9480689B1 (en) * 2015-11-17 2016-11-01 Animal Biotech, LLC Pheromone composition to stimulate reproduction in female suids and methods of use
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
BR112019002250A2 (pt) 2016-08-02 2019-05-14 Texas Tech University System composição, método de modificar o comportamento em um animal, e método para modificar comportamento em um cão
JP2021506279A (ja) * 2017-12-13 2021-02-22 テキサス テック ユニヴァーシティー システムＴｅｘａｓ Ｔｅｃｈ Ｕｎｉｖｅｒｓｉｔｙ Ｓｙｓｔｅｍ 発情の早期開始を刺激し春機発動前後のイノシシ科動物の繁殖供用における必要労力を軽減するためのフェロモン組成物及び使用方法
CN111532108A (zh) * 2020-05-12 2020-08-14 中国科学院心理研究所 雌甾四烯的新用途

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3681490A (en) * 1969-07-22 1972-08-01 Nat Res Dev Artificial insemination of pigs
US4620531A (en) * 1983-10-26 1986-11-04 Dyer Jack L Breeding phenomenon
US5155045A (en) * 1985-01-25 1992-10-13 Trustees Of The University Of Penn. Use of male essence to alter female endocrine response
US4879244A (en) * 1985-01-25 1989-11-07 Monell Chemical Senses Center Birth control method involving monitoring of axillary androstenol and dehydroepiandrosterone
US4931403A (en) * 1985-01-25 1990-06-05 Monell Chemical Senses Center Axillary androstenol and dehydroepiandrosterone as fertile period onset indicators
US4670401A (en) * 1985-01-25 1987-06-02 Monell Chemical Senses Center Axillary androstenol and dehydroepiandrosterone as fertile period onset indicators
US6331534B1 (en) * 1994-08-04 2001-12-18 Pherin Pharmaceuticals, Inc. Steroids as neurochemical stimulators of the VNO to alleviate pain
US6117860A (en) * 1994-08-04 2000-09-12 Pherin Pharmaceuticals, Inc. Steroids as neurochemical stimulators of the VNO to treat paroxistic tachycardia
US6057439A (en) * 1994-08-04 2000-05-02 Pherin Corporation Steroids as neurochemical stimulators of the VNO to alleviate symptoms of PMS and anxiety
DE19735790A1 (de) * 1997-08-18 1999-02-25 Henkel Kgaa Mikroemulsionen
UA74141C2 (uk) * 1998-12-09 2005-11-15 Дж.Д. Сірл Енд Ко. Фармацевтична композиція на основі тонкоподрібненого еплеренону (варіанти), спосіб її одержання та спосіб лікування розладів, опосередкованих альдостероном (варіанти)
WO2001041732A1 (en) * 1999-12-06 2001-06-14 Gore Stanley L Compositions and methods for intranasal delivery of active agents to the brain
JP3448006B2 (ja) * 2000-03-29 2003-09-16 独立行政法人食品総合研究所 機能性エマルション
FR2811561B1 (fr) * 2000-07-13 2003-03-21 Oreal Composition, notamment cosmetique, renfermant la dhea et/ou un precurseur ou derive chimique ou biologique de celle-ci, et un inhibiteur de metalloproteinase
FR2811566B1 (fr) * 2000-07-13 2003-01-17 Oreal Composition, notamment cosmetique, renfermant la dhea et/ou ses precurseurs ou derives, et une vitamine
EP1205108A3 (de) * 2000-10-02 2002-06-12 Bayer Ag Wirkstoffhaltige Emulsionen
US6806293B1 (en) * 2001-03-12 2004-10-19 Darley Pharmaceuticals Ltd Use of pheromone compounds having MAP kinase modulating activity

Also Published As

Publication number Publication date
CA2606275C (en) 2009-03-24
CA2606275A1 (en) 2006-11-16
EP1881836A1 (en) 2008-01-30
CN101217964A (zh) 2008-07-09
BRPI0520265A2 (pt) 2009-09-15
WO2006119604A1 (en) 2006-11-16
US20060252738A1 (en) 2006-11-09
EP1881836A4 (en) 2009-11-25

Similar Documents

Publication Publication Date Title
MX2007013298A (es) Metodo para preparar y usar composiciones de feromona esteroide basadas en agua.
US9642895B2 (en) Peptides for enhancing transdermal delivery
CY1113060T1 (el) Συνθεση αφρου πιμεκρολιμους που περιεχει εξυλενογλυκολη, προαιρετικα ελαϊκη αλκοολη, διμεθυλισοσορβιδη και/ή μεσης αλυσιδας τριγλυκεριδια
TW200507874A (en) Immunostimulatory nucleic acid oil-in-water formulations and related methods of use
JP6486562B2 (ja) 雌のイノシシ科動物における繁殖を刺激するフェロモン組成物及び使用方法
HUE026644T2 (en) Mixture for transdermal administration of low and high molecular weight compounds
NO20070859L (no) Insulinoligomerkonjugater, formuleringer og anvendelser derav.
MX2010008468A (es) Acidos nucleicos de la formula (i) (nug1xmgnnv)a y derivados de los mismos como un agente/adyuvante inmunoestimulante.
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
TNSN07087A1 (en) Stable liquid formulations of plasmid dna
ATE398997T1 (de) Selbst-nanoemulgierende ölige formulierung zur verabreichung von schwer wasserlöslichen arzneimitteln
JP2016527188A5 (es)
TW200510392A (en) Chemical compounds
Falagas et al. Imiquimod for the treatment of actinic keratosis: a meta-analysis of randomized controlled trials
UA96794C2 (ru) Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе
WO2001038303A3 (fr) Analogues de la vitamine d
TW200505452A (en) Chemical compounds
ZA201902384B (en) Compounds and compositions for treating leishmaniasis and methods of diagnosis and treating using same
WO2015081904A3 (en) Polyurethaneurea solutions for compositions with active ingredients or fragrances
JP2003002840A5 (es)
Lindholm et al. Comparison of deslorelin and histrelin for induction of ovulation in mares
AU2011219546B2 (en) Fungal nail treatment composition
MX2020010834A (es) Formulacion solida de mezclas insecticidas.
MX2008015323A (es) Composicion farmaceutica que comprende ciclobenzaprina y aceclofenac en asociacion.
Sanchez et al. Symbiont-derived sphingolipids regulate inflammatory responses in rainbow trout (Oncorhynchus mykiss)

Legal Events

Date Code Title Description
FA Abandonment or withdrawal